FIELD: medicine, pharmacy. SUBSTANCE: invention relates to production of drugs used at atherosclerosis. An agent has heparinoid and additional substances and made as a tablet covered by envelope in the dosed medicinal form. An agent has lactose, calcium stearate and talc as additional agents and covered with acid-resistant envelope mass part of that is from 3.5 to 10% of tablet mass. An acid-resistant envelope has acetylphthalylcellulose, titanium dioxide and castor oil and components are taken in grams per a tablet. EFFECT: high pharmacological activity of antisclerotic effect. 2 cl, 3 tbl, 3 ex
Authors
Dates
1999-04-20—Published
1998-06-03—Filed